We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

7 hedge funds and large institutions have $5.16M invested in Aldeyra Therapeutics in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital inflows, than outflows

Capital inflows: $116K | Capital outflows: $108K

0.13% more ownership

Funds ownership: 15.31% → 15.44% (+0.13%)

0% more funds holding

Funds holding: 7 → 7 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$110K
2
UBS
UBS
Switzerland
+$4.48K
3
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
+$1.77K
4
Citigroup
Citigroup
New York
+$204

Top Sellers

Rank Fund Capital Flow
1
EEG
E.E. Geduld
-$105K
2
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$1.78K
3
GSC
Ground Swell Capital
South Carolina
-$1K

ALDX Hedge Fund Activity: Q3 2014 in Review

7 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q3 2014, worth a combined $5.16M — down 8.4% from $5.64M a quarter earlier.

Fund positioning in ALDX was balanced in Q3 2014: 4 funds opened new positions, 4 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $110K. The largest seller was E.E. Geduld, exiting entirely with an estimated $105K sold.

  • 7 institutional investors held Aldeyra Therapeutics (ALDX) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $5.16M of Aldeyra Therapeutics stock for Q3 2014, down 8.4% quarter-over-quarter.
  • 4 funds opened new Aldeyra Therapeutics positions in Q3 2014 and 4 closed out, a net change of 0 holders.
  • The largest Aldeyra Therapeutics buyer in Q3 2014 was Geode Capital Management, an estimated $110K added.
  • The largest Aldeyra Therapeutics seller in Q3 2014 was E.E. Geduld, an estimated $105K sold.

Based on aggregated 13F filings for Q3 2014.